Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking three high-profile Wall Street picks and putting them under the microscope...
Industrial stocks have been a casualty of Donald Trump's trade war, writes Barron's. In a recent column, the business journal noted that the Industrial Select Sector SPDR ETF, a proxy for industrial stocks as a whole, has lagged the performance of the broader S&P 500 in 2018. And yet, over the past month, both the S&P 500 and the Industrial SPDR have been trending upwards. One analyst thinks the time has come for three industrial stocks in particular -- Caterpillar (NYSE:CAT), Manitowoc (NYSE:MTW), and Helios Technologies (NASDAQ:SNHY) -- to rake in some gains.
Here's what you need to know.
Baird just upgraded three big industrial stocks. Let's dig into the logic. Image source: Getty Images.
Top 10 Medical Stocks To Invest In 2021: Xcerra Corporation(XCRA)
Xcerra Corporation (Xcerra or the Company), formerly known as LTX-Credence Corporation, is a global provider of test and handling capital equipment, interface products, test fixtures and related services to the semiconductor and electronics manufacturing industries. We design, manufacture and market products and services that address the broad, divergent requirements of the mobility, industrial, medical, automotive and consumer end markets, offering a comprehensive portfolio of solutions and technologies, and a global network of strategically deployed applications and support resources. We operate in the semiconductor and electronics manufacturing test markets through our atg-Luther & Maelzer, Everett Charles Technologies (ECT), LTX-Credence and Multitest businesses. Advisors' Opinion:
- [By Garrett Baldwin]
Get an exclusive invitation to meet Tim before everyone else right here.
Three Stocks to Watch Today: LC, GE, GS General Electric Co. (NYSE: GE) has ousted its CEO John Flannery. Shares are up more than 10% as investors celebrated the news. GE has been mired in a slump, particularly its turbine business. The firm's new CEO is H. Lawrence Culp, Jr., the former CEO of the industrial firm Danaher. Shares of LendingClub Corp. (NYSE: LC) are under pressure after the SEC charged one of the firm's divisions with mishandling client money. This weekend, the firm reached a settlement with regulators on charges that the firm inflated its revenue and made changes to products to make the firm look healthier than it is. As a result, the firm's board of directors forced CEO Renaud Laplanche to resign. Goldman Sachs Group Inc. (NYSE: GS) has replaced CEO Lloyd Blankfein, who has stepped down after more than a decade at the helm at one of Wall Street's most iconic banks. David Solomon – who has previously served as the firm's president and COO – will now bet the new CEO. His tenure begins at a tough time for Goldman as the bank struggles with lower trading desk revenues. Look for earnings reports today from Cal-Maine Foods Inc. (NASDAQ: CALM) and Xcerra Corp. (NASDAQ: XCRA).Follow Money Morning on Facebook, Twitter, and LinkedIn.
- [By Rich Smith]
"Robust industry trends" in the semiconductor industry, argues Davidson, give this "leading provider of semiconductor test handlers and ... emerging player in the associated contactor and vision inspection markets" an "ample runway for growth." Cohu's also in the process of acquiring one of its top competitors, Xcerra Corporation (NASDAQ:XCRA), in a deal slated to close next quarter, which will add scale to Cohu's business even as it removes a source of price competition.
- [By Garrett Baldwin]
The system that could make you $104,000 richer in the next 12 months…
Darden Restaurants Inc. (NYSE: DRI) leads a fairly busy day of earnings reports. The restaurant management giant easily topped Wall Street profit numbers by reporting earnings per share of $1.34. The average Wall Street estimate was $1.23. The firm also easily topped revenue expectations. DRI shares were up 4.5% this morning. The problems continue to mount for General Electric Co. (NYSE: GE). This morning, JPMorgan Securities slashed its price target for the U.S. conglomerate from $11 to $10 per share. The investment firm cited ongoing challenges to the company's turbine business. General Electric has been under pressure since the financial crisis, and it was the worst performing stock on the Dow in 2017 before it was ultimately replaced on the index. Shares of Under Armour Inc. (NYSE: UAA) added 3.4% this morning, but the driver wasn't necessarily positive for the global apparel giant. According to reports, the Baltimore-based sports apparel giant is cutting 3% of its international workforce. That equates to roughly 400 jobs. The company did raise its fiscal 2018 earnings forecast, and issued a revised update of severance costs. Look for earnings reports from Micron Technology Inc. (NASDAQ: MU), Thor Industries Inc. (NYSE: THO), United Natural Foods Inc. (NASDAQ: UNFI), Steelcase Inc. (NYSE: SCS), Scholastic Corp. (NASDAQ: SCHL), and Xcerra Corp. (NASDAQ: XCRA).Follow Money Morning on Facebook, Twitter, and LinkedIn.
- [By Garrett Baldwin]
The system that could make you $104,000 richer in the next 12 months…
Shares of Tilray Inc. (NYSE: TLRY) surged more than 50% in pre-market hours. The stock popped after the company's CEO Brendan Kennedy told CNBC that partnerships between marijuana companies and alcohol companies and pharmaceutical giants may be on the way. Kennedy said that he believes alcohol firms should enter the cannabis sector in order to hedge against the growth of cannabis. Tesla Inc. (NASDAQ: TSLA) is under scrutiny this morning. The electric car manufacturer said that the Justice Department has requested documents around the recent batch of tweets sent by CEO Elon Musk about plans to take his company private. The U.S. Securities and Exchange Commission (SEC) has also sent subpoenas to Goldman Sachs and Silver Lake, which have acted as advisers to and evaluated Tesla's goal of going private. Musk's announcement on Twitter in August sent shares of TSLA soaring. However, his statement may have violated federal regulations because Musk failed to file an 8-K notification form with the SEC before the announcement. Shares of Netflix Inc. (NASDAQ: NFLX) were on the move after the stock received an upgrade from Guggenheim Securities. The investment firm hiked its price target from $360 to $420 per share and said that the company's local content strategy will bolster demand in India. The stock maintained its "Buy" rating. Look for additional earnings reports from Red Hat Inc. (NYSE: RHT), Copart Inc. (NASDAQ: CPRT), Herman Miller Inc. (NASDAQ: MLHR), and Xcerra Corp. (NASDAQ: XCRA).Follow Money Morning on Facebook, Twitter, and LinkedIn.
Top 10 Medical Stocks To Invest In 2021: Marcus & Millichap, Inc.(MMI)
Marcus & Millichap, Inc., incorporated on June 4, 2013, is a brokerage firm specializing in commercial real estate investment sales, financing, research and advisory services. The Company also offers market research, consulting and advisory services to its clients. It also offers two services to its clients, such as commercial real estate investment brokerage, and financing and ancillary services. It has over 1,600 investment sales and financing professionals in over 80 offices in the United States and Canada that provide investment brokerage and financing services to sellers and buyers of commercial real estate.
The Company divides the commercial real estate market into four segments: Properties with prices approximately $1 million; Private client market, which includes properties priced from $1 million to $10 million; Middle market, which includes properties priced from $10 million to $20 million, and Institutional market, which includes properties priced from $20 million and above. The Company offers different types of properties, such as multifamily, retail, self-storage, hospitality, seniors housing, multifamily tax credit, affordable housing and manufactured housing.
The Company provides its financing services through Marcus & Millichap Capital Corporation (MMCC). MMCC is a broker of debt financing for commercial properties. The Company also provides research, advisory and consulting services to assist clients in forming their investment strategy and making transaction decisions. The Company also provides a range of advisory and consulting services to developers, lenders, owners, real estate investment trusts, high net worth individuals, pension fund advisors and other institutions. The advisory services include opinions of value, operating and financial performance benchmarking analysis, specific asset buy-sell strategies, market and submarket analysis and ranking, portfolio strategies by property type, market strategy, and development and redevelopment feasibility stu! dies.
The Company competes with CBRE Group, Inc., Cushman & Wakefield, Colliers International, HFF, Inc., Jones Lang LaSalle, Walker & Dunlop, Berkadia Commercial Mortgage LLC, Grandbridge Real Estate Capital and NorthMarq Capital, LLC.
Advisors' Opinion:- [By Motley Fool Transcribers]
Marcus & Millichap Inc (NYSE:MMI)Q4 2018 Earnings Conference CallFeb. 20, 2019, 5:00 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Shane Hupp]
Marcus & Millichap (NYSE:MMI) was downgraded by analysts at JMP Securities from an “outperform” rating to a “market perform” rating in a report issued on Wednesday, Marketbeat reports.
Top 10 Medical Stocks To Invest In 2021: Summit Hotel Properties, Inc.(INN)
Summit Hotel Properties, Inc., a hotel investment company, engages in acquiring, owning, renovating, repositioning, and asset-managing and selling premium-branded limited-service and select-service hotels in the upscale and midscale without food and beverage segments of the United States' lodging industry. As of August 3, 2012, the company operated 74 hotels with a total of 7,586 guestrooms located in 20 states. Summit Hotel Properties, Inc. was founded in 2004 and is based in Sioux Falls, South Dakota.
Innova (CURRENCY:INN) traded 3.2% lower against the dollar during the 24 hour period ending at 15:00 PM E.T. on February 16th. One Innova coin can now be bought for approximately $0.0145 or 0.00000399 BTC on exchanges. Innova has a total market capitalization of $73,312.00 and approximately $50.00 worth of Innova was traded on exchanges in the last 24 hours. Over the last week, Innova has traded down 19.6% against the dollar. COPYRIGHT VIOLATION WARNING: “Summit Hotel Properties Inc (INN) to Issue Quarterly Dividend of $0.18” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this news story can be read at https://www.tickerreport.com/banking-finance/4125733/summit-hotel-properties-inc-inn-to-issue-quarterly-dividend-of-0-18.html. Municipal Employees Retirement System of Michigan trimmed its stake in shares of Summit Hotel Properties Inc (NYSE:INN) by 29.1% during the second quarter, HoldingsChannel reports. The firm owned 29,520 shares of the real estate investment trust’s stock after selling 12,110 shares during the period. Municipal Employees Retirement System of Michigan’s holdings in Summit Hotel Properties were worth $422,000 at the end of the most recent reporting period. Ballard Power Systems Inc. (Ballard), incorporated on November 12, 2008, is engaged in the design, development, manufacture, sale and service of fuel cell products for a range of applications. The Company is focused on its power product markets of heavy-duty motive (consisting of bus and tram applications), portable power, material handling and telecom backup power, as well as the delivery of technology solutions, including engineering services, and the license and sale of its intellectual property portfolio and fundamental knowledge for a range of fuel cell applications. The Company operates in the Fuel Cell Products and Services segment. The Company offers products in three product classes: Fuel cell stacks, Fuel cell modules and Fuel cell systems. The Company's fuel cell and non-fuel cell products, include FCveloCity Fuel Cell Products, including FCveloCity-9SSL, FCveloCity-1020ACS and FCveloCity modules, and FCgen Fuel Cell Products and System Products, including FCgen-1020ACS, ElectraGen-H2 and ElectraGen-ME. The Company provides fuel cell modules for public transit systems, including buses and light rail. The Company designs and manufactures the FCveloCity fuel cell module platform, which in various forms is capable of delivering 30 kilowatts to 200 kilowatts of power for use in the heavy duty motive market. The Company supplies the fuel cell modules to hybrid drive, bus and light rail manufacturer customers that deliver zero-emission fuel cell-powered vehicles to transit operators around the world. Ballard provides FCgen and FCveloCity fuel cell stacks to original equipment manufacturer (OEM) customers and system integrators that use the stacks to produce fuel cell systems for power solutions. Ballard builds the stacks into self-contained FCveloCity motive modules that are plug-and-play into a larger system. Ballard also builds fuel cell systems for stationary power markets that are designed to solve certain energy needs of its customers. The ElectraGen product lines provide fuel-f! lexible (hydrogen and methanol) system solutions for Backup power markets. Ballard's technology solutions offering primarily involves the provision of engineering services and customer access through licensing to Ballard's intellectual property portfolio. The Company has research and development, testing, manufacturing and service facilities in Burnaby, British Columbia. In the United States, the Company has research and development facilities in Bend, Oregon, and has a sales, manufacturing, and research and development facility in Southborough, Massachusetts. The Company uses a contract manufacturing facility in Tijuana, Mexico. The Company also has a sales, service and research and development facility in Hobro, Denmark. The Company competes with Hydrogenics, Nedstack, Horizon Fuel Cell, Smart Fuel Cell, Hyster-Yale, Dantherm Power, Altergy, Plug Power, FuelCon, Greenlight Innovation, Intelligent Energy and Ricardo. Will fuel cells be the next "best thing since sliced bread"? Or has the once-promising technology already started going the way of the typewriter and the unsliced commercial loaf? Well, two of the leading fuel cell companies, Ballard Power Systems (NASDAQ:BLDP) and Bloom Energy (NYSE:BE), are working hard to make sure it's the former. Let's take a look at both of them to see which one is the better buy. Ballard Power Systems Inc. (NASDAQ:BLDP) Q4 and Full Year 2018 Earnings Conference Call March. 07, 2019, 8:00 a.m. ET Operator Shares of Ballard Power Systems (NASDAQ:BLDP) fell 10% on Thursday morning before recovering somewhat, after the hydrogen fuel cell maker reported a fourth-quarter loss of $0.06 per share, missing estimates by $0.04, on revenue that was down nearly 30% year over year. The results threaten to stymie what had been an impressive run for the shares, which were up more than 40% year to date after a difficult 2018. Get a free copy of the Zacks research report on Ballard Power Systems (BLDP) For more information about research offerings from Zacks Investment Research, visit Zacks.com Trina Solar Limited operates as an integrated solar-power products manufacturer and solar system developer in the People's Republic of China, Europe, the United States, and other Asia Pacific regions. The company designs, develops, manufactures, and sells photovoltaic (PV) modules comprising monocrystalline and multicrystalline PV modules ranging in various power outputs for use in residential, commercial, industrial, and other solar power generation systems. It also provides mono- and multi-crystalline silicon ingots, wafers, cells, and related products, as well as PV modules based on customer and end-user specifications. In addition, the company designs, constructs, sells, and/or operates solar power projects. Trina Solar Limited sells its products to power plant developers and operators, distributors, wholesalers, PV system integrators, and regional and national grid operators. The company has a strategic cooperation framework agreement with the Administrative Committee of the Hefei Xinzhan General Pilot Zone to develop up to 300 MW of distributed generation solar power and related projects in Hefei, Anhui Province. Trina Solar Limited was founded in 1997 and is headquartered in Changzhou, the People's Republic of China. Energo (CURRENCY:TSL) traded 7.5% higher against the U.S. dollar during the 24-hour period ending at 16:00 PM ET on September 9th. During the last seven days, Energo has traded 10.7% lower against the U.S. dollar. Energo has a total market cap of $2.64 million and $127,840.00 worth of Energo was traded on exchanges in the last 24 hours. One Energo token can now be bought for approximately $0.0044 or 0.00000069 BTC on exchanges including Coinnest, Gate.io, CoinEgg and CoinBene. ThinkSmart (LON:TSL)‘s stock had its “corporate” rating reiterated by investment analysts at FinnCap in a report issued on Thursday. Shares of Tree Island Steel Ltd. (TSE:TSL) reached a new 52-week low on Tuesday . The stock traded as low as C$2.55 and last traded at C$2.56, with a volume of 3500 shares trading hands. The stock had previously closed at C$2.58. Abbott Laboratories is an Illinois corporation, incorporated in 1900. Abbott's* principal business is the discovery, development, manufacture, and sale of a broad and diversified line of health care products. FINANCIAL INFORMATION RELATING TO INDUSTRY SEGMENTS, GEOGRAPHIC AREAS, AND CLASSES OF SIMILAR PRODUCTS Incorporated herein by reference is Note 15 entitled "Segment and Geographic Area Information" of the Notes to Consolidated Financial Statements included under Item 8, "Financial Statements and Supplementary Data." NARRATIVE DESCRIPTION OF BUSINESS Abbott has four reportable segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. Prior to January 1, 2013, Abbott had five reportable segments, which included Proprietary Pharmaceutical Products. Advisors' Opinion: The Delta variant is also on Cramer's radar, as restrictions on indoor activities will have continued impacts on restaurants and travel, but will be good for Regeneron (REGN) - Get Report and Abbott Labs (ABT) - Get Report, makers of COVID treatments and testing. Abbott Laboratories (NYSE:ABT) insider Roger Bird sold 9,188 shares of the business’s stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $79.06, for a total value of $726,403.28. Following the sale, the insider now owns 60,195 shares in the company, valued at $4,759,016.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. You won't find many if any blue-chip healthcare stocks that are "bluer" than Abbott Laboratories (NYSE:ABT) and Johnson & Johnson (NYSE:JNJ). Both companies have been around since the late 19th century. Both are Dividend Aristocrats with decades of consecutive dividend increases. Canadian National Railway Company, together with its subsidiaries, engages in the rail and related transportation business in North America. It provides transportation for various goods, including petroleum and chemicals, grain and fertilizers, coal, metals and minerals, forest products, and intermodal and automotive products. The company operates a network of approximately 20,600 route miles of track that spans Canada and mid-America, from the Atlantic and Pacific oceans to the Gulf of Mexico. It serves the ports of Vancouver, Prince Rupert (British Columbia), Montreal, Halifax, New Orleans, and Mobile (Alabama), as well as metropolitan areas of Toronto, Buffalo, Chicago, Detroit, Duluth (Minnesota)/Superior (Wisconsin), Green Bay (Wisconsin), Minneapolis/St. Paul, Memphis, and Jackson (Mississippi), with connections to various points in North America. The company was founded in 1922 and is headquartered in Montreal, Canada. Canadian National Railway Co (NYSE:CNI)Q1 2019 Earnings CallApril 29, 2019, 4:30 p.m. ET Operator Canadian National Railway (NYSE:CNI) (TSE:CNR) has been assigned a consensus recommendation of “Hold” from the twenty brokerages that are covering the firm, Marketbeat.com reports. Twelve equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 1-year price target among brokers that have covered the stock in the last year is $93.33. BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer, and inflammatory diseases. It uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry, and computer to develop new therapeutic candidates. The company has three novel late-stage compounds in development, which include Peramivir, a neuraminidase inhibitor for the potential treatment of influenza; BCX4208, a purine nucleoside phosphorylase (PNP) inhibitor for gout; and Forodesine, a PNP inhibitor for cutaneous T-cell lymphoma (CTCL) and chronic lymphocytic leukemia (CLL). Peramivir is being developed under a contract from the Biomedical Advanced Research and Development Authority within the United States Department of Health and Human Services. Forodesine has been granted orphan drug status by the FDA for thr ee indications, which include T-cell non-Hodgkin?s lymphoma, including CTCL; CLL and related leukemias, including T-cell prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia; and for treatment of B-ALL. The FDA has also granted fast track status to the development of forodesine for the treatment of relapsed or refractory T-cell leukemia, and special protocol assessment from the FDA for forodesine to conduct a pivotal clinical trial in CTCL with an oral formulation. The company announced the initiation of a Phase 2b study of BCX4208 as add-on therapy in gout patients who have not responded to allopurinol therapy alone. BioCryst Pharmaceuticals utilizes crystallography and structure-based drug design to discover additional compounds and to progress others through pre-clinical and early development to address the unmet medical needs of patients and physicians. The company was founded in 1986 and is headquartered in Durham, North Carolina. Biocryst Pharmaceuticals Inc (NASDAQ:BCRX)Q4 2018 Earnings Conference CallMarch 04, 2019, 8:30 a.m. ET Operator Get a free copy of the Zacks research report on BioCryst Pharmaceuticals (BCRX) For more information about research offerings from Zacks Investment Research, visit Zacks.com Shares of BioCryst Pharmaceuticals (NASDAQ:BCRX) rose over 21% last month, according to data provided by S&P Global Market Intelligence. In the beginning of the month, the company announced the successful sale of 10.4 million shares that raised around $57.5 million in gross proceeds. Portola Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics for patients in the areas of thrombosis, other hematologic disorders, and inflammation. Its lead compound, Betrixaban, is an oral, once-daily Factor Xa inhibitor in Phase III clinical trial for venous thromboembolism prophylaxis in acute medically ill patients in-hospital and post discharge. The company's other lead development candidate, Andexanet alfa, a recombinant protein that is in Phase III registration studies designed to reverse the anticoagulant activity in patients treated with a Factor Xa inhibitor who suffer an uncontrolled bleeding episode or undergo emergency surgery. It has collaboration agreements with Biogen Idec Inc.; Bristol-Myers Squibb Company; Pfizer Inc.; Bayer Pharma, AG; Janssen Pharmaceuticals, Inc.; Daiichi Sankyo, Inc.; and Lee's Pharmaceutical (HK) Ltd. The company is also developing Cerdulatinib, which is in Phase I/IIa proof-of-concept study, an orally available kinase inhibitor that inhibits spleen tyrosine kinase and janus kinases enzymes, which regulate signaling pathways, as well as for hematologic, or blood, cancers, and inflammatory disorders. In addition, it is involved in the development of PRT2607, a selective Syk inhibitor. Portola Pharmaceuticals, Inc. has a collaboration with Bristol-Myers Squibb and Pfizer Inc. to develop and commercialize apixaban, an oral anticoagulant. The company was founded in 2003 and is headquartered in South San Francisco, California. Portola Pharmaceuticals Inc (NASDAQ:PTLA)Q4 2018 Earnings Conference CallMarch 01, 2019, 8:30 a.m. ET Operator After it reported fourth-quarter results and solidified its cash position without issuing more shares, Portola Pharmaceuticals (NASDAQ:PTLA) shares had gained 15.3% at noon EST on Friday. Valero Energy Partners LP, incorporated on July 24, 2013, owns, operates, develops and acquires crude oil and refined petroleum products pipelines, terminals, and other transportation and logistics assets. The Company's assets include crude oil and refined petroleum products pipeline and terminal systems in the United States Gulf Coast and the United States Mid-Continent regions that are integral to the operations of the following Valero Energy Corporation (Valero) refineries, such as Port Arthur Refinery-Port Arthur, Texas; McKee Refinery-Sunray, Texas; Three Rivers Refinery-Three Rivers, Texas; Memphis Refinery-Memphis, Tennessee; Ardmore Refinery-Ardmore, Oklahoma; St. Charles Refinery-Norco, Louisiana; Houston Refinery-Houston, Texas, and Corpus Christi East and West Refineries-Corpus Christi, Texas. Port Arthur Logistics System The Company's Port Arthur logistics system includes its Lucas crude system and its Port Arthur products system. Its Lucas crude system supports diverse and flexible crude oil supply options for Valero's Port Arthur Refinery. The Lucas crude system comprises Lucas Terminal, Lucas Pipeline, Nederland Pipeline, TransCanada Connection and Seaway Connection. Its Lucas terminal is located over 10 miles from Valero's Port Arthur Refinery on approximately 500 acres. The facility consists of over seven storage tanks with an aggregate of approximately 1.9 million barrels of storage capacity. The Lucas terminal receives crude oil through its Nederland pipeline, which connects to the Sunoco Logistics Partners L.P. marine terminal in Nederland, Texas, as well as through connections to the Cameron Highway crude oil pipeline and Enterprise's Beaumont marine terminal. Its Lucas pipeline is an approximately 12-mile, 30-inch pipeline with over 400,000 barrels per day of capacity. The Nederland pipeline is an approximately five-mile, 32-inch pipeline with over 600,000 barrels per day of capacity. Its TransCanada connection has over 400,000 barrels per day of capacit! y. The Seaway connection has over 750,000 barrels per day of capacity. The Company's Port Arthur products system transports refined petroleum products from Valero's Port Arthur Refinery to third-party pipeline systems, including the Explorer, Colonial, Sunoco Logistics MagTex and Enterprise TE Products refined petroleum products pipeline systems, for delivery to various marketing outlets, and to Enterprise's Beaumont marine terminal for exports. Its Port Arthur products system comprises Port Arthur Products Pipelines (Port Arthur Products Station (PAPS)-El Vista); 12-10 Pipeline, and PAPS and El Vista Terminals. Port Arthur products pipelines consist of an approximately four-mile, 20-inch pipeline with over 144,000 barrels per day of capacity. Its 12-10 pipeline consists of over 13 miles of approximately 12-inch and 10-inch pipeline with over 60,000 barrels per day of capacity. The PAPS terminal consists of over eight tanks with approximately 821,000 barrels of diesel storage capacity, and the Company's El Vista terminal consists of over eight tanks with approximately 1.2 million barrels of gasoline storage capacity. Its PAPS terminal also contains storage tanks owned by Colonial. McKee Logistics System The Company's McKee logistics system is a crude oil and refined petroleum products pipeline and terminal system supporting Valero's McKee Refinery in Sunray, Texas. The McKee logistics system includes the Company's McKee crude system and McKee products system. The McKee crude system supplies crude oil to Valero's McKee Refinery located. The McKee products system transports refined petroleum products from Valero's McKee Refinery to the Company's refined petroleum products terminal in El Paso, Texas and on to Kinder Morgan's SFPP system for marketing in the southwest the United States. McKee products system comprises McKee to El Paso pipeline, which consists of over 410 miles of approximately 10-inch pipeline with a capacity of over 63,000 barrels per day. SFPP pipeli! ne connec! tion consists of approximately 10 miles of 16- and 8-inch pipelines that deliver diesel and gasoline from the El Paso terminal to Kinder Morgan's SFPP system. The SFPP pipeline connection has over 98,400 barrels per day of capacity. The El Paso terminal is located on approximately 120 acres and consists of over 10 storage tanks with approximately 499,000 barrels of storage capacity. The El Paso terminal receives refined petroleum products delivered to the terminal through the Company's McKee to El Paso pipeline. Memphis Logistics System The Company's Memphis logistics system includes its Collierville crude system and Memphis products system. The Collierville crude system is the primary crude oil supply source for Valero's Memphis Refinery, which delivers crude oil from the Capline pipeline and consists of Collierville Pipeline System, Collierville Terminal and St. James Crude Tank. The Collierville pipeline system consists of over 52 miles of 10- to 20-inch pipelines with approximately 210,000 barrels per day of capacity that deliver crude oil to Valero's Memphis Refinery. The Collierville terminal is located in Byhalia, Mississippi on over 60 acres. The facility consists of approximately three storage tanks with over 975,000 barrels of storage capacity. The Company owns an approximately 330,000 barrel crude oil storage tank in St. James, Louisiana. The Company's Memphis products system is the outlet for refined petroleum products produced at Valero's Memphis Refinery with distribution through the Memphis truck rack and its terminal in West Memphis, Arkansas, for further distribution through truck and barge to marketing outlets along the central Mississippi River, to Exxon's Memphis refined petroleum products terminal, and to the Memphis International Airport. Memphis products system comprises Shorthorn Pipeline System, Memphis Airport Pipeline System, West Memphis Terminal and Memphis Truck Rack. The Shorthorn pipeline system consists of over seven miles of approx! imately 1! 4-inch pipeline that delivers diesel and gasoline produced at Valero's Memphis Refinery to the Company's West Memphis terminal and over two miles of 12-inch pipeline that delivers diesel and gasoline from its West Memphis terminal and Valero's Memphis Refinery to Exxon's Memphis refined petroleum products terminal. The Shorthorn pipeline system has a total capacity of over 120,000 barrels per day. The Company's Memphis Airport pipeline system consists of an approximately nine-mile, six-inch pipeline that delivers jet fuel produced at Valero's Memphis Refinery to the Swissport Fueling, Inc. terminal located at the Memphis International Airport, and an approximately two-mile, six-inch pipeline that delivers jet fuel from Valero's Memphis Refinery to the FedEx jet fuel terminal located at the Memphis International Airport. The Memphis Airport pipeline system has a total capacity of over 20,000 barrels per day. West Memphis terminal is located in West Memphis, Arkansas on over 75 acres. The facility consists of approximately 20 storage tanks with over one million barrels of storage capacity, a truck rack, and a barge dock on the Mississippi River. The terminal delivers refined petroleum products to the five-bay, 50,000 barrels per day truck rack at the terminal, the Company's two-berth, 4,000 barrels per hour barge dock on the Mississippi River and its Shorthorn pipeline system for deliveries to Exxon's Memphis terminal. Memphis truck rack consists of seven-bay truck rack and over five biodiesel storage tanks with approximately 8,000 barrels of storage capacity. The truck rack has a capacity of over 110,000 barrels per day. Three Rivers Crude System The Company's Three Rivers crude system supports Valero's Three Rivers Refinery located in the Eagle Ford shale region in South Texas. The Three Rivers crude system consists of approximately 10 crude oil truck unloading sites with lease automatic custody transfer units and over three 1-mile, 12-inch pipelines with a capacit! y of appr! oximately 110,000 barrels per day. The system delivers crude oil received from the truck unloading sites and pipeline connections to tanks at Valero's Three Rivers Refinery. The system also receives locally produced crude oil through connections to the Harvest Arrowhead pipeline system and the Plains Gardendale pipeline for processing at the Three Rivers Refinery or for shipment through third-party pipelines to Valero's refineries in Corpus Christi, Texas. Wynnewood Products System The Company's Wynnewood products system is the distribution outlet for refined petroleum products from Valero's Ardmore Refinery. The Wynnewood products system consists of an approximately 30-mile, 12-inch refined petroleum products pipeline with over 90,000 barrels per day of capacity and approximately two tanks with a total of over 180,000 barrels of storage capacity. The system connects Valero's Ardmore Refinery to the Magellan refined products pipeline system. Houston Terminal The Company's Houston terminal is a crude oil, intermediates and refined petroleum products terminal that supports Valero's Houston Refinery. The terminal is located on the Houston ship channel and has storage tanks with over 3.6 million barrels of storage capacity. The terminal receives waterborne crude oil through the refinery's docks and the terminal's connection to Houston Fuel Oil Terminal Company (HFOTCO), and receives pipeline crude oil through the Magellan and Seaway systems. The terminal can distribute refined petroleum products across the refinery's docks and into the Magellan South Pipeline system. St. Charles Terminal The Company's St. Charles terminal is a crude oil, intermediates and refined petroleum products terminal that supports Valero's St. Charles Refinery. The terminal is located on the Mississippi River and has storage tanks with over 10 million barrels of storage capacity. The terminal receives crude oil through the refinery's docks and from Louisian! a Offshor! e Oil Port (LOOP) through the Clovelly pipeline. The terminal can distribute refined petroleum products across the refinery's docks and into the Plantation through Parkway and Colonial through Bengal pipeline systems. Corpus Christi Terminals The Company's Corpus Christi terminals are engaged in the business of terminaling crude oil, intermediates and refined petroleum products in Corpus Christi, Texas. The Corpus Christi East terminal supports Valero's Corpus Christi East Refinery. The Corpus Christi East terminal is located on the Corpus Christi ship channel and has storage tanks with over 6.2 million barrels of storage capacity. The Corpus Christi West terminal supports Valero's Corpus Christi West Refinery. The Corpus Christi West terminal is located on the Corpus Christi ship channel and has storage tanks with over 3.8 million barrels of storage capacity. Valero Energy Partners (NYSE:VLP) was upgraded by equities researchers at ValuEngine from a “strong sell” rating to a “sell” rating in a research report issued to clients and investors on Tuesday. US Capital Advisors downgraded shares of Valero Energy Partners (NYSE:VLP) from an overweight rating to a hold rating in a report released on Friday morning, The Fly reports. Valero Energy Partners (NYSE:VLP) last posted its earnings results on Thursday, July 26th. The pipeline company reported $0.66 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.66. The company had revenue of $134.63 million for the quarter, compared to analyst estimates of $132.71 million. Valero Energy Partners had a return on equity of 108.14% and a net margin of 46.87%. Valero Energy Partners’s revenue was up 21.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.69 earnings per share. sell-side analysts forecast that Valero Energy Partners LP will post 2.78 EPS for the current fiscal year. Shell Midstream Partners (NYSE: SHLX) and Valero Energy Partners (NYSE:VLP) are both mid-cap oils/energy companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership. Top 10 Medical Stocks To Invest In 2021: Ballard Power Systems, Inc.(BLDP)
Top 10 Medical Stocks To Invest In 2021: Trina Solar Limited(TSL)
Top 10 Medical Stocks To Invest In 2021: Abbott Laboratories(ABT)
Top 10 Medical Stocks To Invest In 2021: Canadian National Railway Company(CNI)
Top 10 Medical Stocks To Invest In 2021: BioCryst Pharmaceuticals Inc.(BCRX)
Top 10 Medical Stocks To Invest In 2021: Portola Pharmaceuticals, Inc.(PTLA)
Top 10 Medical Stocks To Invest In 2021: Valero Energy Partners LP(VLP)
No comments:
Post a Comment